Earnings Feed
Start Free
U.S. Stem Cell, Inc.·4

Dec 20, 4:17 PM ET

TOMAS MIKE 4

4 · U.S. Stem Cell, Inc. · Filed Dec 20, 2019

Insider Transaction Report

Form 4
Period: 2019-09-01
U.S. Stem Cell, Inc.USRM
TOMAS MIKE
DirectorCEO & President
Transactions
  • Award

    Stock Option (right to buy)

    2019-09-01+20,000,000→ 80,041,284 total
    Exercise: $0.01Exp: 2029-09-01→ Common Stock (20,000,000 underlying)
  • Award

    Stock Option (right to buy)

    2019-11-18+1,500,000→ 81,541,284 total
    Exercise: $0.00From: 2019-11-18Exp: 2029-11-18→ Common Stock (1,500,000 underlying)
Holdings

  • Common Stock

    9,793
Footnotes (1)
  • [F1]5,000,000 vest on 09/01/2020, 5,000,000 vest on 09/01/2021, 5,000,000 vest on 09/01/2022, 5,000,000 vest on 09/01/2023.

Documents

1 file
  • 4
    ownership.xmlPrimary